• Fri, September 9, 2022
Andrew Galler Initiated (VIR) at Sell and Held Target at $15 on, Sep 9th, 2022
Andrew Galler of Morgan Stanley, Initiated "Vir Biotechnology, Inc." (VIR) at Sell and Held Target at $15 on, Sep 9th, 2022.
Andrew has made no other calls on VIR in the last 4 months.
There is 1 other peer that has a rating on VIR. Out of the 1 peers that are also analyzing VIR, 0 agree with Andrew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andrew
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $125 on, Thursday, May 12th, 2022
Like: 👍
